These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 10480797)

  • 1. Fasting blood glucose and risk of cardiovascular disease.
    Balkau B; Jarrett RJ; Pyörälä K; Eschwège E
    Diabetes Care; 1999 Aug; 22(8):1385-7. PubMed ID: 10480797
    [No Abstract]   [Full Text] [Related]  

  • 2. Relations of Postload and Fasting Glucose With Incident Cardiovascular Disease and Mortality Late in Life: The Cardiovascular Health Study.
    Brutsaert EF; Shitole S; Biggs ML; Mukamal KJ; deBoer IH; Thacker EL; Barzilay JI; Djoussé L; Ix JH; Smith NL; Kaplan RC; Siscovick DS; Psaty BM; Kizer JR
    J Gerontol A Biol Sci Med Sci; 2016 Mar; 71(3):370-7. PubMed ID: 26314953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visit-to-Visit Variability of Fasting Plasma Glucose and the Risk of Cardiovascular Disease and All-Cause Mortality in the General Population.
    Wang A; Liu X; Xu J; Han X; Su Z; Chen S; Zhang N; Wu S; Wang Y; Wang Y
    J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29187392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated post-challenge hyperglycaemia and risk of cardiovascular events: Tehran Lipid and Glucose Study.
    Barzin M; Hosseinpanah F; Malboosbaf R; Hajsheikholeslami F; Azizi F
    Diab Vasc Dis Res; 2013 Jul; 10(4):324-9. PubMed ID: 23291339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implications of fasting plasma glucose in subjects with echocardiographic abnormalities.
    Pareek M; Vaduganathan M; Bhatt DL; Leósdóttir M; Olsen MH
    Int J Cardiol; 2017 Aug; 241():423-429. PubMed ID: 28314485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fasting glucose levels, incident diabetes, subclinical atherosclerosis and cardiovascular events in apparently healthy adults: A 12-year longitudinal study.
    Sitnik D; Santos IS; Goulart AC; Staniak HL; Manson JE; Lotufo PA; Bensenor IM
    Diab Vasc Dis Res; 2016 Nov; 13(6):429-437. PubMed ID: 27488360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose.
    Qiao Q; Pyörälä K; Pyörälä M; Nissinen A; Lindström J; Tilvis R; Tuomilehto J
    Eur Heart J; 2002 Aug; 23(16):1267-75. PubMed ID: 12175663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low fasting glucose is associated with enhanced thrombin generation and unfavorable fibrin clot properties in type 2 diabetic patients with high cardiovascular risk.
    Gajos G; Konieczynska M; Zalewski J; Undas A
    Cardiovasc Diabetol; 2015 May; 14():44. PubMed ID: 25928628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose patterns during an oral glucose tolerance test and associations with future diabetes, cardiovascular disease and all-cause mortality rate.
    Hulman A; Vistisen D; Glümer C; Bergman M; Witte DR; Færch K
    Diabetologia; 2018 Jan; 61(1):101-107. PubMed ID: 28983719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired Fasting Glucose in Nondiabetic Range: Is It a Marker of Cardiovascular Risk Factor Clustering?
    Valentino G; Kramer V; Orellana L; Bustamante MJ; Casasbellas C; Adasme M; Salazar A; Navarrete C; Acevedo M
    Dis Markers; 2015; 2015():804739. PubMed ID: 26504260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High fasting serum glucose in non-diabetic subjects ≥45 years is an indicator of future cardiovascular events as it is positively associated with atherogenic index of plasma.
    Sharma N; Baliarsingh S
    Arch Physiol Biochem; 2012 May; 118(2):43-6. PubMed ID: 22530931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of diabetes and impaired fasting glucose in Costa Rica: Costa Rican National Cardiovascular Risk Factors Survey, 2010.
    Wong-McClure R; Gregg EW; Barcelo A; Sanabria-Lopez L; Lee K; Abarca-Gomez L; Cervantes-Loaiza M; Luman ET
    J Diabetes; 2016 Sep; 8(5):686-92. PubMed ID: 26516694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity in children and future cardiometabolic risk: are blood tests necessary?
    Logue J; Sattar N
    Diabetes Care; 2010 Dec; 33(12):2711-2. PubMed ID: 21115774
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality.
    Shaw JE; Hodge AM; de Courten M; Chitson P; Zimmet PZ
    Diabetologia; 1999 Sep; 42(9):1050-4. PubMed ID: 10447514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absolute change in fasting plasma glucose over 12 months is associated with 2-year and 5-year major adverse cardiovascular events in patients with drug-eluting stent implants.
    Kang DO; Seo HS; Choi BG; Lee E; Kim JP; Lee SK; Im SI; Na JO; Choi CU; Lim HE; Kim JW; Kim EJ; Rha SW; Park CG; Oh DJ
    Int J Cardiol; 2015 Jan; 179():146-52. PubMed ID: 25464435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-high-density-lipoprotein cholesterol and cardiovascular risk factors among adolescents with and without impaired fasting glucose.
    Liu J; Joshi D; Sempos CT
    Appl Physiol Nutr Metab; 2009 Apr; 34(2):136-42. PubMed ID: 19370043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of change in fasting glucose on the risk of myocardial infarction, stroke, and all-cause mortality: a nationwide cohort study.
    Lee G; Kim SM; Choi S; Kim K; Jeong SM; Son JS; Yun JM; Park SM
    Cardiovasc Diabetol; 2018 Apr; 17(1):51. PubMed ID: 29626936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of factors differentially associated with isolated impaired fasting glucose and isolated post-load impaired glucose tolerance: the Hong Kong Cardiovascular Risk Factor Study.
    Thomas GN; Schooling CM; McGhee SM; Ho SY; Cheung BM; Wat NM; Janus ED; Lam TH;
    Eur J Endocrinol; 2006 Oct; 155(4):623-32. PubMed ID: 16990663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired fasting glucose and cardiovascular disease.
    Perry IJ
    Diabetes Care; 1999 Nov; 22(11):1919-20. PubMed ID: 10546043
    [No Abstract]   [Full Text] [Related]  

  • 20. Classical cardiovascular risk factors according to fasting plasma glucose levels.
    Martinez-Hervas S; Romero P; Hevilla EB; Real JT; Priego A; Martin-Moreno JM; Carmena R; Ascaso JF
    Eur J Intern Med; 2008 May; 19(3):209-13. PubMed ID: 18395166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.